Evidence map›Paper›PMID 35630172›Full record

ArticleMicromachines2022

Microfluidic Paper-Based Blood Plasma Separation Device as a Potential Tool for Timely Detection of Protein Biomarkers.

Francisco Burgos-Flórez, Alexander Rodríguez, Eliana Cervera, Marcio De Ávila, Marco Sanjuán, Pedro J Villalba

Open access · goldAbstract read
In one paragraph

Article in Micromachines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Francisco Burgos-FlórezBiotechnology Research Group, Universidad del Norte, Barranquilla 081007, Colombia.ORCID 0000-0002-5381-1398
Alexander RodríguezBiotechnology Research Group, Universidad del Norte, Barranquilla 081007, Colombia.ORCID 0000-0001-6424-7254
Eliana CerveraBiotechnology Research Group, Universidad del Norte, Barranquilla 081007, Colombia.ORCID 0000-0002-7098-1620
Marcio De ÁvilaBiotechnology Research Group, Universidad del Norte, Barranquilla 081007, Colombia.ORCID 0000-0001-7637-5106
Marco SanjuánRational Use of Energy and Preservation of the Environment Group (UREMA), Universidad del Norte, Barranquilla 081007, Colombia.
Pedro J VillalbaBiotechnology Research Group, Universidad del Norte, Barranquilla 081007, Colombia.ORCID 0000-0003-3015-0299
Universidad del Norte · CO

Funding

Colciencias 757-2016Gobernación del Atlántico 809-2018
6 · The paper itself

Abstract

A current challenge regarding microfluidic paper-based analytical devices (µPAD) for blood plasma separation (BPS) and electrochemical immunodetection of protein biomarkers is how to achieve a µPAD that yields enough plasma to retain the biomarker for affinity biosensing in a functionalized electrode system. This paper describes the development of a BPS µPAD to detect and quantify the S100B biomarker from peripheral whole blood. The device uses NaCl functionalized VF2 filter paper as a sample collection pad, an MF1 filter paper for plasma retention, and an optimized microfluidic channel geometry. An inverted light microscope, scanning electron microscope (SEM), and image processing software were used for visualizing BPS efficiency. A design of experiments (DOE) assessed the device's efficacy using an S100B ELISA Kit to measure clinically relevant S100B concentrations in plasma. The BPS device obtained 50 μL of plasma from 300 μL of whole blood after 3.5 min. The statistical correlation of S100B concentrations obtained using plasma from standard centrifugation and the BPS device was 0.98. The BPS device provides a simple manufacturing protocol, short fabrication time, and is capable of S100B detection using ELISA, making one step towards the integration of technologies aimed at low-cost POC testing of clinically relevant biomarkers.

Indexed as

blood plasma separationELISAmicrofluidicspaperTBI biomarkers

Identifiers

PMID35630172
PMCPMC9142996
OpenAlexW4225124433

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.